1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Results of conventional cytogenetics and interphase FISH (I-FISH) analyses in patients with a clinical and morphologic diagnosis of CML: Analysis of 52 cases
    Meeting Abstract

    Gupta, S.; Berman, E.; Jhanwar, S.
    Blood (2004)

    Fulltext@MSK | Save
  • Tositumomab and iodine I 131 tositumomab (the BEXXAR (R) therapeutic regimen) shows efficacy in elderly patients (pts) with relapsed/refractory low-grade (LG), follicular, and transformed non-Hodgkin's lymphoma (NHL)
    Meeting Abstract

    Gregory, S. A.; Zelenetz, A.; Knox, S. J.; Vose, J.; Leonard, J. P.; Kaminski, M.
    Blood (2004)

    Fulltext@MSK | Save
  • The iodine I-131 tositumomab therapeutic regimen: Summary of safety in 995 patients with relapsed/refractory low grade (LG) and transformed LG non-Hodgkin's lymphoma (NHL)
    Meeting Abstract

    Gregory, S. A.; Leonard, J. P.; Knox, S. J.; Zelenetz, A. D.; Armitage, J.; Kaminiski, M.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Lymphocyte function and molecular mechanisms of enhanced immune reconstitution following sex steroid ablation and hemopoietic stem cell transplantation (HSCT)
    Meeting Abstract

    Goldberg, G. L.; Alpdogan, O.; Muriglan, S. J.; Hammett, M.; Milton, M. K.; Eng, J. M.; Hubbard, V. M.; Kochman, A.; Willis, L. M.; Greenberg, A. S.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • Recombinant soluble prostate-specific membrane antigen (rsPSMA) vaccine: Preliminary findings of a phase I safety/immunogenicity trial
    Meeting Abstract

    Gardner, J. P.; Slovin, S. F.; Morrissey, D. M.; Donovan, G. P.; Surowitz, K. G.; Olson, W. C.; Scher, H. I.; Israel, R. J.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Evolution of Rituximab as "standard" therapy in patients (pts) with newly diagnosed follicular (FL), mantle cell (MCL), and diffuse large B cell (DLCL) non-Hodgkin's lymphoma (NHL) in 5 United States comprehensive cancer centers: An analysis from the national comprehensive cancer network (NCCN) NHL outcomes project
    Meeting Abstract

    Friedberg, J. W.; Kho, M. E.; Lepisto, E. M.; Rodriguez, M. A.; TerVeer, A.; LaCasce, A. S.; Nademanee, A. P.; Millenson, M.; Czuczman, M.; Niland, J.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • 3-Dimensional multi-modality non-invasive imaging of the bone marrow engraftment model
    Meeting Abstract

    Doubrovin, M.; Mayer-Kuckuk, P.; Budak-Alpdogan, T.; Bidaut, L.; Cai, S.; Ponomarev, V.; Blasberg, R.; Van Den Brink, M.; Bertino, J.; Benarjee, D.; more...
    Biology of Blood and Marrow Transplantation (2004)

    Fulltext@MSK | Save
  • DNA immunization against melanoma antigens enhances tumor immunity in mouse models of allogeneic hematopoietic stem cell transplantation (HSCT)
    Meeting Abstract

    Diab, A.; Perales, M. A.; Cohen, A.; Hubbard, V. M.; Eng, J.; Huggins, D.; Engelhorn, M.; Guevara, J. A; Alpdogan, O.; Wolchok, J. D.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • DNA immunization against melanoma antigens enhances tumor immunity in mice following sub-lethal irradiation and immune reconstitution
    Meeting Abstract

    Diab, A.; Hubbard, V. M.; Cohen, A.; Huggins, D.; Kochman, A.; Guevara, J. A; Engelhorn, M.; Wolchok, J. D.; Van Den Brink, M.; Houghton, A. N.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • Phase II evaluation of the tyrosine kinase inhibitor MLN518 in patients with acute myeloid leukemia (AML) bearing a FLT3 internal tandem duplication (ITD) mutation
    Meeting Abstract

    De Angelo, D. J.; Stone, R. M.; Heaney, M. L.; Nimer, S. D.; Paquette, R.; Bruner-Klisovic, R.; Caligiuri, M. A.; Cooper, M. R.; Le-Cerf, J. M.; Iyer, G.
    Blood (2004)

    Fulltext@MSK | Save